NOT-AG-23-019: Notice of Early Expiration of PAR-21-112, "Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (T32)"

Notice of Early Expiration of PAR-21-112, "Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (T32)"

Notice Number:

NOT-AG-23-019

Key Dates

Release Date:

April 11, 2023

Related Announcements

January 22, 2021 - Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (T32). See NOFO PAR-21-112.
April 11, 2023 - Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed). See NOFO PAR-23-163.

Issued by

National Institute on Aging (NIA)

Purpose

This notice informs that, effective immediately, PAR-21-112, “Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (T32)” is terminated.

PAR-21-112 has been reissued as PAR-23-163, “Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed).”

Unlike PAR-21-112, “Renewal” is an allowable application type of PAR-23-163.

Inquiries

Please direct all inquiries to:

Yuan Luo, Ph.D.
National Institute on Aging (NIA)
Division of Neuroscience (DN)
Telephone: 301-496-9350
Fax: 301-496-1494
Email: [email protected]